Green Vision Biotechnology Corp. (GVBT) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
ROOMS 1804-06, 18/F, WING ON HOUSE HONG KONG SAR, 00000 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 287 - Agricultural Chemicals (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2022 MRQ | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 1/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 7 | 27 | 62 | 9 | 39 | ||||
| Cash and cash equivalents | 7 | 27 | 62 | 9 | 39 | ||||
| Receivables | 23 | 22 | 31 | 21 | 65 | ||||
| Inventory, net of allowances, customer advances and progress billings | 278 | ||||||||
| Inventory | 278 | ||||||||
| Other undisclosed current assets | 0 | 2 | 6 | 6 | 46 | ||||
| Total current assets: | 30 | 51 | 99 | 37 | 428 | ||||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 2,073 | 2,163 | 2,161 | 2,363 | 3,013 | ||||
| Intangible assets, net (including goodwill) | 818 | 822 | 793 | 827 | 883 | ||||
| Intangible assets, net (excluding goodwill) | 818 | 822 | 793 | 827 | 883 | ||||
| Other undisclosed noncurrent assets | 1 | 1 | 2 | 2 | 40 | ||||
| Total noncurrent assets: | 2,892 | 2,985 | 2,956 | 3,192 | 3,937 | ||||
| TOTAL ASSETS: | 2,922 | 3,036 | 3,055 | 3,228 | 4,365 | ||||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 350 | 322 | 221 | 234 | 213 | 7 | |||
| Taxes payable | 17 | 6 | 0 | 23 | 10 | ||||
| Employee-related liabilities | 18 | 13 | 12 | 34 | 20 | ||||
| Accounts payable | 20 | 27 | 26 | 28 | 31 | ||||
| Accrued liabilities | 295 | 276 | 183 | 149 | 152 | ||||
| Other undisclosed accounts payable and accrued liabilities | 7 | ||||||||
| Debt | 50 | ||||||||
| Other liabilities | 264 | 255 | 244 | 38 | 47 | ||||
| Due to related parties | 5,797 | 5,746 | 5,590 | 5,310 | 5,301 | 50 | |||
| Customer advances and deposits | ✕ | ✕ | ✕ | ✕ | ✕ | 0 | |||
| Other undisclosed current liabilities | 4,428 | 4,128 | 3,915 | 4,051 | 3,896 | ||||
| Total current liabilities: | 10,839 | 10,451 | 9,970 | 9,634 | 9,457 | 107 | |||
| Noncurrent Liabilities | |||||||||
| Total liabilities: | 10,839 | 10,451 | 9,970 | 9,634 | 9,457 | 107 | |||
| Equity | |||||||||
| Equity, attributable to parent | (7,916) | (7,415) | (6,915) | (6,405) | (5,092) | (107) | |||
| Common stock | 161 | 161 | 161 | 161 | 161 | 61 | |||
| Additional paid in capital | (282) | (282) | (282) | (282) | (282) | (17) | |||
| Accumulated other comprehensive loss | (157) | (155) | (51) | (38) | (88) | ||||
| Accumulated deficit | (7,638) | (7,138) | (6,742) | (6,245) | (4,883) | (151) | |||
| Total equity: | (7,916) | (7,415) | (6,915) | (6,405) | (5,092) | (107) | |||
| TOTAL LIABILITIES AND EQUITY: | 2,922 | 3,036 | 3,055 | 3,228 | 4,365 | ||||
Income Statement (P&L) ($ in thousands)
| 6/30/2022 TTM | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 1/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 145 | 87 | 80 | 100 | 135 | |||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | 135 | ||
| Cost of revenue | (74) | (93) | (68) | (78) | (82) | |||
| Cost of goods and services sold | (68) | (78) | (82) | |||||
| Gross profit: | 71 | (7) | 12 | 21 | 53 | |||
| Operating expenses | (617) | (518) | (551) | 678 | (1,994) | (70) | ||
| Other operating expense, net (Other Expenses) | (21) | |||||||
| Other undisclosed operating income (loss) | 1,089 | (1,758) | ||||||
| Operating income (loss): | 521 | (525) | (538) | (1,059) | (1,941) | (70) | ||
| Nonoperating income | 44 | 377 | 258 | |||||
| Other nonoperating income | 44 | 377 | 260 | |||||
| Interest and debt expense | (4) | (4) | (2) | 3 | ||||
| Income (loss) from continuing operations: | 517 | (529) | (497) | (679) | (1,683) | (70) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | 517 | (529) | (497) | (679) | (1,683) | (70) | |
| Net income (loss): | 517 | (529) | (497) | (679) | (1,683) | (70) | ||
| Other undisclosed net income (loss) attributable to parent | (1,017) | 133 | 0 | (683) | ||||
| Net loss attributable to parent: | (500) | (396) | (497) | (1,362) | (1,683) | (70) | ||
| Other undisclosed net income available to common stockholders, basic | 4 | |||||||
| Net loss available to common stockholders, diluted: | (500) | (392) | (497) | (1,362) | (1,683) | (70) | ||
Comprehensive Income ($ in thousands)
| 6/30/2022 TTM | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 1/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 517 | (529) | (497) | (679) | (1,683) | (70) | ||
| Other comprehensive income (loss) | 2 | 104 | 13 | (49) | 87 | |||
| Comprehensive income (loss): | 520 | (425) | (484) | (728) | (1,597) | (70) | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (1,022) | (75) | (25) | (585) | ||||
| Comprehensive loss, net of tax, attributable to parent: | (502) | (500) | (509) | (1,313) | (1,597) | (70) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.